Fetal health study using a telehealth platform in Missouri
Part of Women’s health & pregnancy clinical trials.
This trial tests whether a home monitoring device linked to a telehealth platform can safely reduce the number of in-person fetal nonstress tests (NSTs) needed for pregnant people with certain conditions. It may help you by offering more convenient monitoring between 32 and 40 weeks of pregnancy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and speak English.
- You are pregnant with one baby (not twins, triplets, etc.).
- You have Missouri Medicaid or private insurance (study can cover costs if needed).
- Your doctor says you need fetal testing (NST) between 32 and 40 weeks because of conditions like gestational diabetes, well-controlled type 2 diabetes, chronic high blood pressure, advanced age, or obesity (BMI 30–45).
- You own a smartphone or tablet (Android or Apple) and have reliable internet at home or work.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial lets you monitor your baby's heartbeat at home with a simple device instead of coming to the hospital each time. It's for women with certain high-risk pregnancy conditions who are 32 weeks or more along.
This study tests a special device that monitors the health of you and your twin babies during the final weeks of pregnancy. It aims to see how well the device works for twins.
This study tests if personalized stress-reduction care during pregnancy can lower the risk of preterm birth, especially for those at higher risk. It is for people with a singleton pregnancy between 8 and nearly 20 weeks who receive care at UNC Chapel Hill.
This trial tests a remote digital care system to monitor your pregnancy at home if you have a complication that requires regular CTG (fetal heartbeat) checks. The goal is to see if this home monitoring is safe and accessible, reducing the need for hospital visits.
This study tests if women with high-risk pregnancies can safely use a remote monitor at home instead of staying in the hospital. You would use a belly patch to send your baby's heart rate and your contractions to your care team.
This trial is testing a new system called Femom, which monitors your baby's heartbeat during pregnancy, to see if it works as well as the standard method. If you're at least 32 weeks pregnant with one baby, you may be able to join.
Hear when a new Pregnancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.